GBI Bio Appoints Jesse McCool, Ph.D., as Chief Executive Officer
Biopharmaceutical industry veteran will lead GBI's continued advancement toward commercial-scale manufacturing and expansion of its early-stage biologics capabilities. FORT LAUDERDALE, Fla., Sept. 10, 2026 /PRNewswire/ -- GBI Biomanufacturing, Inc., ("GBI"/ "Goodwin Biotechnology...
Read more »